Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.

Mascarenhas J, Kosiorek H, Prchal J, Yacoub A, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Salama ME, Weinberg RS, Rampal R, Goldberg JD, Mesa R, Dueck AC, Hoffman R.

Leukemia. 2019 Jul 30. doi: 10.1038/s41375-019-0524-7. [Epub ahead of print] No abstract available.

PMID:
31363161
2.

Multipotent fetal-derived Cdx2 cells from placenta regenerate the heart.

Vadakke-Madathil S, LaRocca G, Raedschelders K, Yoon J, Parker SJ, Tripodi J, Najfeld V, Van Eyk JE, Chaudhry HW.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11786-11795. doi: 10.1073/pnas.1811827116. Epub 2019 May 20.

3.

A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature.

Levavi H, Tripodi J, Marcellino B, Mascarenhas J, Jones AV, Cross NCP, Gruenstein D, Najfeld V.

Acta Haematol. 2019;142(2):105-112. doi: 10.1159/000498945. Epub 2019 May 7.

PMID:
31063994
4.

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53.

Marcellino BK, Hoffman R, Tripodi J, Lu M, Kosiorek H, Mascarenhas J, Rampal RK, Dueck A, Najfeld V.

Blood Adv. 2018 Dec 26;2(24):3581-3589. doi: 10.1182/bloodadvances.2018024018.

5.

Genomic characterization of spleens in patients with myelofibrosis.

Zimran E, Tripodi J, Rampal R, Rappoport F, Zirkiev S, Hoffman R, Najfeld V.

Haematologica. 2018 Oct;103(10):e446-e449. doi: 10.3324/haematol.2018.193763. Epub 2018 May 10. No abstract available.

6.

Reappraising hyalinizing clear cell carcinoma: A population-based study with molecular confirmation.

Hernandez-Prera JC, Kwan R, Tripodi J, Chiosea S, Cordon-Cardo C, Najfeld V, Demicco EG.

Head Neck. 2017 Mar;39(3):503-511. doi: 10.1002/hed.24637. Epub 2016 Nov 29.

PMID:
27898192
7.

Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplification.

Hanna MG, Najfeld V, Irie HY, Tripodi J, Nayak A.

Springerplus. 2015 Aug 21;4:439. doi: 10.1186/s40064-015-1235-9. eCollection 2015.

8.

Double minute amplification of mutant PDGF receptor α in a mouse glioma model.

Zou H, Feng R, Huang Y, Tripodi J, Najfeld V, Tsankova NM, Jahanshahi M, Olson LE, Soriano P, Friedel RH.

Sci Rep. 2015 Feb 16;5:8468. doi: 10.1038/srep08468.

9.

JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis.

Wang X, Ye F, Tripodi J, Hu CS, Qiu J, Najfeld V, Novak J, Li Y, Rampal R, Hoffman R.

Blood. 2014 Nov 6;124(19):2987-95. doi: 10.1182/blood-2014-02-558015. Epub 2014 Sep 5.

10.

BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia.

Wang X, Tripodi J, Kremyanskaya M, Blouin A, Roda P, Hoffman R, Najfeld V.

Blood. 2013 Feb 14;121(7):1238-9. doi: 10.1182/blood-2012-11-467787. No abstract available.

11.

Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.

Wang X, Prakash S, Lu M, Tripodi J, Ye F, Najfeld V, Li Y, Schwartz M, Weinberg R, Roda P, Orazi A, Hoffman R.

J Clin Invest. 2012 Nov;122(11):3888-99.

12.

Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells.

Lu M, Wang X, Li Y, Tripodi J, Mosoyan G, Mascarenhas J, Kremyanskaya M, Najfeld V, Hoffman R.

Blood. 2012 Oct 11;120(15):3098-105. doi: 10.1182/blood-2012-02-410712. Epub 2012 Aug 7.

13.

Oncogene-mediated alterations in chromatin conformation.

Rickman DS, Soong TD, Moss B, Mosquera JM, Dlabal J, Terry S, MacDonald TY, Tripodi J, Bunting K, Najfeld V, Demichelis F, Melnick AM, Elemento O, Rubin MA.

Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9083-8. doi: 10.1073/pnas.1112570109. Epub 2012 May 21.

14.

Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation.

Kara RJ, Bolli P, Karakikes I, Matsunaga I, Tripodi J, Tanweer O, Altman P, Shachter NS, Nakano A, Najfeld V, Chaudhry HW.

Circ Res. 2012 Jan 6;110(1):82-93. doi: 10.1161/CIRCRESAHA.111.249037. Epub 2011 Nov 14. Erratum in: Circ Res. 2015 Nov 6;117(11):e91.

15.

Multiploid inheritance of HIV-1 during cell-to-cell infection.

Del Portillo A, Tripodi J, Najfeld V, Wodarz D, Levy DN, Chen BK.

J Virol. 2011 Jul;85(14):7169-76. doi: 10.1128/JVI.00231-11. Epub 2011 May 4.

16.

Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression.

Najfeld V, Wisch N, Mascarenhas J, Issa L, Tripodi J, Sidhu M, Hoffman R.

Cancer Genet. 2011 Mar;204(3):165-70. doi: 10.1016/j.cancergencyto.2010.09.001.

PMID:
21504717
17.

Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production.

Iancu-Rubin C, Gajzer D, Tripodi J, Najfeld V, Gordon RE, Hoffman R, Atweh GF.

Blood. 2011 Apr 28;117(17):4580-9. doi: 10.1182/blood-2010-09-305540. Epub 2011 Mar 1.

18.

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms.

Tripodi J, Hoffman R, Najfeld V, Weinberg R.

Cancer Manag Res. 2010 Sep 17;2:219-23. doi: 10.2147/CMR.S12829.

19.

Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.

Wang X, Zhang W, Tripodi J, Lu M, Xu M, Najfeld V, Li Y, Hoffman R.

Blood. 2010 Dec 23;116(26):5972-82. doi: 10.1182/blood-2010-02-269696. Epub 2010 Sep 21.

20.

Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia.

Najfeld V, Tripodi J, Scalise A, Silverman LR, Silver RT, Fruchtman S, Hoffman R.

Br J Haematol. 2010 Nov;151(3):288-91. doi: 10.1111/j.1365-2141.2010.08355.x. Epub 2010 Aug 25. No abstract available.

PMID:
20738298
21.

Contemplations on preclinical validation of fluorescence in situ hybridization probe assay for paraffin-embedded tissues in hematologic disorders.

Reddy KS, Tripodi J.

Cancer Genet Cytogenet. 2008 May;183(1):1-5. doi: 10.1016/j.cancergencyto.2008.01.015.

PMID:
18474289
22.

Ion transport across the cecum in normal and colitic mice.

Homaidan FR, Tripodi J, Cheng P, Donovan V, Burakoff R.

Dig Dis Sci. 1999 Aug;44(8):1539-46.

PMID:
10492130
23.

Fulminant hepatic failure.

Bernstein D, Tripodi J.

Crit Care Clin. 1998 Apr;14(2):181-97. Review.

PMID:
9561813
24.

Regulation of ion transport by histamine in mouse cecum.

Homaidan FR, Tripodi J, Zhao L, Burakoff R.

Eur J Pharmacol. 1997 Jul 23;331(2-3):199-204.

PMID:
9274980
25.

Surgical clips as a nidus for stone formation in the common bile duct.

Rizzo J, Tripodi J, Gold B, Opper F.

J Clin Gastroenterol. 1995 Sep;21(2):169-71. No abstract available.

PMID:
8583087
26.

Primary adenocarcinoma of the appendix: an unusual presentation.

Tripodi J, Perlmutter S, Rudansky S, Kim DK, Burakoff R.

Am J Gastroenterol. 1995 Apr;90(4):661-2. No abstract available.

PMID:
7717334
27.

Infarction of an epiploic appendage. Review of the literature.

Desai HP, Tripodi J, Gold BM, Burakoff R.

J Clin Gastroenterol. 1993 Jun;16(4):323-5. Review.

PMID:
8331268
28.

A case of diversion colitis treated with 5-aminosalicylic acid enemas.

Tripodi J, Gorcey S, Burakoff R.

Am J Gastroenterol. 1992 May;87(5):645-7.

PMID:
1595655

Supplemental Content

Loading ...
Support Center